Management of Congenital Long-QT Syndrome: Commentary From the Experts-Reference-Cited by-同舟云学术

Management of Congenital Long-QT Syndrome: Commentary From the Experts

Published:2021-07 Issue:7 Volume:14 Page:
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ: Arrhythmia and Electrophysiology

Author:

Kaufman Elizabeth S.¹^ORCID,Eckhardt Lee L.²^ORCID,Ackerman Michael J.³⁴⁵^ORCID,Aziz Peter F.⁶^ORCID,Behr Elijah R.⁷⁸^ORCID,Cerrone Marina⁹,Chung Mina K.¹⁰^ORCID,Cutler Michael J.¹¹,Etheridge Susan P.¹²^ORCID,Krahn Andrew D.¹³^ORCID,Lubitz Steven A.¹⁴^ORCID,Perez Marco V.¹⁵^ORCID,Priori Silvia G.⁸¹⁶¹⁷^ORCID,Roberts Jason D.¹⁸^ORCID,Roden Dan M.¹⁹^ORCID,Schulze-Bahr Eric⁸²⁰,Schwartz Peter J.⁸²¹^ORCID,Shimizu Wataru²²^ORCID,Shoemaker M. Benjamin²³^ORCID,Sy Raymond W.²⁴²⁵,Towbin Jeffrey A.²⁶^ORCID,Viskin Sami²⁷^ORCID,A.M. Wilde Arthur⁸²⁸²⁹^ORCID,Zareba Wojciech³⁰^ORCID

Affiliation:

1. Heart & Vascular Center, MetroHealth Campus, Case Western Reserve University, Cleveland, OH (E.S.K.).

2. Cellular and Molecular Arrhythmia Research Program, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin, Madison (L.L.E.).

3. Departments of Cardiovascular Medicine (M.J.A.), Mayo Clinic, Rochester, MN.

4. Pediatric and Adolescent Medicine (M.J.A.), Mayo Clinic, Rochester, MN.

5. Molecular Pharmacology and Experimental Therapeutics (M.J.A.), Mayo Clinic, Rochester, MN.

6. Pediatric Electrophysiology and Inherited Arrhythmia Clinic, Cleveland Clinic Children’s, OH (P.F.A.).

7. Cardiovascular Clinical Academic Group, Institute of Molecular and Clinical Sciences, St George’s, University of London, St George’s University Hospitals NHS Foundation Trust, United Kingdom (E.R.B.).

8. ERN GUARDHEART members of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart () (E.R.B., S.G.P., E.S.-B., P.J.S., A.A.M.W.).

9. Inherited Arrhythmias Clinic, Leon H. Charney Division of Cardiology, New York University Grossman School of Medicine (M.C.).

10. Heart, Vascular and Thoracic Department, Department of Cardiovascular Medicine, Cleveland Clinic, OH (M.K.C.).

11. Intermountain Medical Center Heart Institute, Intermountain Medical Center, Murray, UT (M.J.C.).

12. Department of Pediatrics, Division of Pediatric Cardiology, University of Utah, Salt Lake City (S.P.E.).

13. Center for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, Canada (A.D.K.).

14. Cardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital, Boston (S.A.L.).

15. Stanford Center for Inherited Cardiovascular Diseases, Stanford University, Palo Alto, CA (M.V.P.).

16. Istituti Clinici Scientifici Maugeri, Pavia, Italy (S.G.P.).

17. Department of Molecular Medicine, University of Pavia, Italy (S.G.P.).

18. Population Health Research Institute, McMaster University and Hamilton Health Sciences, Ontario, Canada (J.D.R.).

19. Senior Vice-President for Personalized Medicine, Vanderbilt University Medical Center, Nashville, TN (D.M.R.).

20. Institute for Genetics of Heart Diseases, University Hospital Münster, Germany (E.S.-B.).

21. Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy (P.J.S.).

22. Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan (W.S.).

23. Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN (M.B.S.).

24. Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, Australia (R.W.S.).

25. Sydney Medical School, University of Sydney, NSW, Australia (R.W.S.).

26. Le Bonheur Children’s Hospital, University of Tennessee Health Science Center, Memphis (J.A.T.).

27. Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Israel (S.V.).

28. Department of Clinical and Experimental Cardiology, University of Amsterdam Heart Center, the Netherlands (A.A.M.W.).

29. Department of Clinical and Experimental Cardiology, Amsterdam, the Netherlands (A.A.M.W.).

30. Clinical Cardiovascular Research Center, University of Rochester Medical Center, NY (W.Z.).

Abstract

While published guidelines are useful in the care of patients with long-QT syndrome, it can be difficult to decide how to apply the guidelines to individual patients, particularly those with intermediate risk. We explored the diversity of opinion among 24 clinicians with expertise in long-QT syndrome. Experts from various regions and institutions were presented with 4 challenging clinical scenarios and asked to provide commentary emphasizing why they would make their treatment recommendations. All 24 authors were asked to vote on case-specific questions so as to demonstrate the degree of consensus or divergence of opinion. Of 24 authors, 23 voted and 1 abstained. Details of voting results with commentary are presented. There was consensus on several key points, particularly on the importance of the diagnostic evaluation and of β-blocker use. There was diversity of opinion about the appropriate use of other therapeutic measures in intermediate-risk individuals. Significant gaps in knowledge were identified.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCEP.120.009726

Reference48 articles.

1. Diagnostic Miscues in Congenital Long-QT Syndrome

2. Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome

3. Prevalence and significance of an isolated long QT interval in elite athletes

4. QT dispersion and meft ventricular hypertrophy in athletes

5. Repeat long QT syndrome genetic testing of phenotype-positive cases: Prevalence and etiology of detection misses

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-natal clues of a genetic tale: how foetal heart rate foretells long QT syndrome;Europace;2023-10-26

2. Etiologies, Mechanisms, Management, and Outcomes of Electrical Storm;Journal of Intensive Care Medicine;2023-09-20

3. Sixty years of the Bruce protocol: reappraising the contemporary role of exercise stress testing with electrocardiographic monitoring;Porto Biomedical Journal;2023-09

4. Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines;Hypertension;2022-06

5. A Brief Introduction to Management of LQTS;Reviews in Cardiovascular Medicine;2022-05-05